CID 134461434

Zelicapavir

Structural Information

Molecular Formula
C27H22F3N7O3
SMILES
C1COCCN1C2=C(N=CC(=C2)C(F)(F)F)C3=NN=C(O3)N[C@@H]4C(=O)NC5=CC=CC=C5C(=N4)C6=CC=CC=C6
InChI
InChI=1S/C27H22F3N7O3/c28-27(29,30)17-14-20(37-10-12-39-13-11-37)22(31-15-17)25-35-36-26(40-25)34-23-24(38)32-19-9-5-4-8-18(19)21(33-23)16-6-2-1-3-7-16/h1-9,14-15,23H,10-13H2,(H,32,38)(H,34,36)/t23-/m1/s1
InChIKey
VGGNPZNYTJXPEW-HSZRJFAPSA-N
Compound name
(3S)-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)pyridin-2-yl]-1,3,4-oxadiazol-2-yl]amino]-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

3
References

14
Patents

549.17365 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 550.18093 228.9
[M+Na]+ 572.16287 238.1
[M+NH4]+ 567.20747 229.7
[M+K]+ 588.13681 235.5
[M-H]- 548.16637 231.8
[M+Na-2H]- 570.14832 232.7
[M]+ 549.17310 230.7
[M]- 549.17420 230.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe